Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prostaglandin E2 binding and cyclic AMP production in isolated bone cells.

R M Dziak, D Hurd, K T Miyasaki

    Calcified Tissue International
    |January 1, 1983
    PubMed
    Summary

    Researchers found specific prostaglandin E2 (PGE2) receptors on bone cells, with osteoclasts showing higher binding capacity than osteoblasts. This difference impacts cellular responses, suggesting distinct roles in bone physiology.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Usefulness of Subtraction Radiography in the Evaluation of Periodontal Therapy.

    Journal of periodontology·2018
    Same author

    Should the concern of myelodysplastic syndrome affect the decision of auto-SCT in lymphoma?

    Bone marrow transplantation·2009
    Same author

    Recombinant interferon-alpha2b added to oral cyclophosphamide either as induction or maintenance in treatment-naive follicular lymphoma: final analysis of CALGB 8691.

    Leukemia & lymphoma·2009
    Same author

    Auto-SCT for AML in second remission: CALGB study 9620.

    Bone marrow transplantation·2009
    Same author

    Salivary biomarkers associated with alveolar bone loss.

    Annals of the New York Academy of Sciences·2007
    Same author

    Economic analysis of unrelated allogeneic bone marrow transplantation: results from the randomized clinical trial of T-cell depletion vs unmanipulated grafts for the prevention of graft-versus-host disease.

    Bone marrow transplantation·2005

    Area of Science:

    • Bone biology
    • Cellular signaling
    • Prostaglandin research

    Background:

    • Prostaglandin E2 (PGE2) is implicated in bone metabolism.
    • Specific receptors for PGE2 in bone cells have been hypothesized but not directly demonstrated.
    • Understanding PGE2 binding is crucial for elucidating its role in bone cell function.

    Purpose of the Study:

    • To provide direct evidence for specific prostaglandin E2 (PGE2) receptors on bone cells.
    • To investigate differences in PGE2 binding among various bone cell types.
    • To correlate PGE2 receptor binding with cellular responses, specifically cyclic AMP production.

    Main Methods:

    • Isolation of bone cells from fetal and newborn rat calvaria using collagenase digestion.
    • Incubation of isolated cells with radiolabeled 3H-PGE2 and measurement of specific binding.

    Related Experiment Videos

  • Competition assays using unlabeled PGE2 analogs to determine binding specificity.
  • Sequential digestion to obtain osteoclastic and osteoblastic cell populations for comparative analysis.
  • Scatchard analysis to determine binding affinity and capacity.
  • Measurement of cyclic AMP (cAMP) response to varying PGE2 concentrations.

    • Main Results:

    • Specific binding of 3H-PGE2 to bone cells reached steady state within 10 minutes.
    • PGE2 binding was inhibited by PGE1 and U44069, but not by PGF2 alpha, lipopolysaccharide, or 13,14-dihydro-15-keto PGE2, indicating receptor specificity.
    • Osteoclastic bone cells exhibited 30-fold higher PGE2 binding than osteoblastic cells.
    • Scatchard analysis showed similar affinity constants but a fivefold greater binding capacity for PGE2 in osteoclastic cells compared to heterogeneous populations.
    • Osteoclastic populations responded to lower PGE2 concentrations with increased cyclic AMP levels than osteoblastic populations.

    Conclusions:

    • Direct evidence for specific prostaglandin E2 (PGE2) receptors on bone cells was established.
    • Significant differences in PGE2 receptor binding capacity exist between osteoclastic and osteoblastic bone cells.
    • These binding differences correlate with cellular cyclic AMP responses, suggesting distinct functional roles for PGE2 in different bone cell types.